New method for calcium on the ADVIA analyzer is free from interference of gadolinium-type contrast agents

Journal of Clinical Laboratory Analysis

Volumn 23, Issue 6, 2009, Pages 399-403

  Datta, Pradip ^a   Dasgupta, Amitava ^b  

^a Siemens Healthcare Diagnostics Inc   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

ADVIA; Calcium; Gadolinium; Interference

Indexed keywords

BILIRUBIN; CALCIUM; GADOLINIUM; HEMOGLOBIN; LIPID;

ANALYZER; ARTICLE; ATOMIC EMISSION SPECTROMETRY; CALCIUM URINE LEVEL; NUCLEAR MAGNETIC RESONANCE;

ARTIFACTS; CALCIUM; CHEMISTRY, CLINICAL; CONTRAST MEDIA; GADOLINIUM; HUMANS; REGRESSION ANALYSIS; SPECTROPHOTOMETRY, ATOMIC;

EID: 73249116849     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20353     Document Type: Article

References (16)

1. Pecherstorfer M, Brenner K, Zojer N. Current management stratigies for hypercalcemia. Tret Endocrinol 2003;2:273-292.
2. Lumachi F, Brunello A, Roma A, Basso U. Cancer induced hypercalcemia. Anticancer Res 2009;29:1551-1555.
3. Lumachi F, Brunello A, Roma A, Basso U. Medical management of malignancy-associted hypercalcemia. Curr Med Chem 2008;15:415-421.
4. Medarov BI. Milk-alkali syndrome. Mayo Clinica Proc 2009;84:261-267.
5. Robertson WG, Marshall RW. CRC Crit. Rev Clin Lab Sci 1979;11:271-304.
6. Zak B, Epstien E, Baginski ES. Review of calcium methodologies. Ann Clin Lab Sci 1975;5:195-215.
7. Hartmann AE, Lewis LR. Evaluation of the ASTRA-Ocresolpthalein complexone calcium method. Am J Clin Pathol 1984;82:182-187.
8. Janssen JW, Helbing AR. Arsenazo III: an improvement of the routine calcium determination in serum. Eur J Clin Chem Clin Biochem 1991;29:197-201.
9. Proctor KA, Rao LV, Roberts WL. Gadolinium magnetic resonance contrast agents produce analytical interference in multiple serum assays. Am J Clin Pathol 2004;121:282-292.
10. Emerson J, Kost G. Spurious hypocalcemia after Omniscan or OptiMark enhanced magnetic resonance imaging: an algorithm for minimizing a false positive laboratory value. Arch Pathol Lab Med 2004;128:1151-1156.
11. Kang HP, Scott MG, Joe BN, et al. Model for predicting the impact of gadolinium on plasma calcium measured by teh O-cresolphthalein method. Clin Chem 2004;50:741-746.
12. Gandhi M, Narra VR, Brown JJ, et al. Clinical and economic impact of falsely decreased calcium values caused by gadoverse-tamide interference. Am J Roentgenol 2008;190:W213-W217.
13. Prince MR, Erel HE, Lent RW, et al. Gadodiamide administration causes spurious hypocalcemia. Radiology 2003;227:639-646.
14. Lin J, Idee JM, Port ME, et al. Interference of magnetic resonance contrast agents with serum calcium measurement technique using colorimetric reagents. J Pharm Biomed Anal 1999;21:931-943.
15. Lowe A, Balzer T, Hirt U. Interference of gadolinium containing contrast enhancing agents with colorimetric calcium laboratory testing. Invest Radiol 2005;40:521-525.
16. Normann PT, Froysa A, Svaland M. Interference of gadodiamide injection (OMNISCAN) on the colorimetric determination on serum calcium. Scand J Clin Lab Invest 1995;55:421-426.